Skip to main content
Fig. 1 | Systematic Reviews

Fig. 1

From: Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas

Fig. 1

P scores for overall survival and progression-free survival according to the network meta-analysis with hazard ratios and restricted mean survival time difference at t* = 10 years. AC adjuvant chemotherapy, CRT concomitant chemoradiotherapy, HR hazard ratio, IC induction chemotherapy, rmstD restricted mean survival time difference, RT radiotherapy

Back to article page

Systematic Reviews

ISSN: 2046-4053